Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, June 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 105 articles:
HTML format


 

Single Articles

  1. RORHOLT M, Ghanima W, Farkas DK, Norgaard M, et al
    Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012.
    Haematologica. 2017 Jun 1. pii: haematol.2016.157008.
    Abstract    

    Abstract available

  2. WANG L, Zheng Q, Yuan Y, Li Y, et al
    Effects of 17beta-estradiol and 2-methoxyestradiol on the oxidative stress-hypoxia inducible factor-1 pathway in hypoxic pulmonary hypertensive rats.
    Exp Ther Med. 2017;13:2537-2543.
    Abstract    

    Abstract available

  3. SUMAN AC, Costa EAPND, Bazan SGZ, Hueb JC, et al
    Evaluating respiratory musculature, quality of life, anxiety, and depression among patients with indeterminate chronic Chagas disease and symptoms of pulmonary hypertension.
    Rev Soc Bras Med Trop. 2017;50:194-198.
    Abstract    

    Abstract available

  4. BANERJEE D, Ventetuolo CE
    Pulmonary Hypertension in Pregnancy.
    Semin Respir Crit Care Med. 2017;38:148-159.
    Abstract    



  5. HIGASHI A, Dohi Y, Yamabe S, Kinoshita H, et al
    Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.
    Heart Vessels. 2017 May 30. doi: 10.1007/s00380-017-0999.
    Abstract    

    Abstract available

  6. GURGHEAN AV, Tudor IA
    Pulmonary hypertension in patients with hepatic cirrhosis and portal hypertension. An echographic study.
    Clujul Med. 2017;90:161-165.
    Abstract    

    Abstract available

  7. GANDHI V, Hewston M, Yadam S, Ma K, et al
    Consequences of Venous Thromboembolism, Including Chronic Thromboembolic Pulmonary Hypertension.
    Crit Care Nurs Q. 2017;40:260-275.
    Abstract    

    Abstract available

  8. KUMAR R, Mickael C, Kassa B, Gebreab L, et al
    TGF-beta activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
    Nat Commun. 2017;8:15494.
    Abstract    

    Abstract available

  9. JIN P, Gu W, Lai Y, Zheng W, et al
    The Circulating MicroRNA-206 Level Predicts the Severity of Pulmonary Hypertension in Patients with Left Heart Diseases.
    Cell Physiol Biochem. 2017;41:2150-2160.
    Abstract    

    Abstract available

  10. KURZYNA M, Darocha S, Pietura R, Pietrasik A, et al
    Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single centre European experience.
    Kardiol Pol. 2017 May 29. doi: 10.5603/KP.a2017.0091.
    Abstract    

    Abstract available

  11. CHIWANE S, Ahmed TM, Bauerfeld CP, Chauhan M, et al
    Pulmonary hypertension and right heart failure due to severe hypernatremic dehydration.
    Perfusion. 2017;32:413-415.
    Abstract    

    Abstract available

  12. LI Y, Wang Y, Meng X, Zhu W, et al
    Assessment of right ventricular longitudinal strain by 2D speckle tracking imaging compared with RV function and hemodynamics in pulmonary hypertension.
    Int J Cardiovasc Imaging. 2017 May 29. doi: 10.1007/s10554-017-1182.
    Abstract    

    Abstract available

  13. WEITSMAN T, Weisz G, Farkash R, Klutstein M, et al
    Pulmonary Hypertension with Left Heart Disease: Prevalence, Temporal Shifts in Etiologies and Outcome.
    Am J Med. 2017 May 25. pii: S0002-9343(17)30529.
    Abstract    

    Abstract available

  14. EBERHARD M, Mastalerz M, Pavicevic J, Frauenfelder T, et al
    Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis.
    Int J Cardiovasc Imaging. 2017 May 26. doi: 10.1007/s10554-017-1180.
    Abstract    

    Abstract available

  15. YAMAZAKI H, Kobayashi N, Taketsuna M, Tajima K, et al
    Safety and effectiveness of tadalafil in patients with pulmonary arterial hypertension: Japanese post-marketing surveillance data.
    Curr Med Res Opin. 2017;33:963-971.
    Abstract    

    Abstract available

  16. PATEL M, Predescu D, Bardita C, Chen J, et al
    Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.
    Am J Pathol. 2017;187:528-542.
    Abstract    

    Abstract available

  17. BURGOS CM, Modee A, Ost E, Frenckner B, et al
    Addressing the causes of late mortality in infants with congenital diaphragmatic hernia.
    J Pediatr Surg. 2016 Sep 5. pii: S0022-3468(16)30304.
    Abstract    

    Abstract available

  18. KROWKA MJ, Fallon MB, Kawut SM, Fuhrmann V, et al
    International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Transplantation. 2016;100:1440-52.
    Abstract    

    Abstract available

  19. DAVEY R, Benza RL, Murali S, Raina A, et al
    Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension.
    Pulm Circ. 2017;7:539-542.
    Abstract    

    Abstract available

  20. BLYTH KG, Bellofiore A, Jayasekera G, Foster JE, et al
    Dobutamine stress MRI in pulmonary hypertension: relationships between stress pulmonary artery relative area change, RV performance, and 10-year survival.
    Pulm Circ. 2017;7:465-475.
    Abstract    

    Abstract available

  21. PARIKH R, Varghese B, Khatoon HN, Kovach JA, et al
    Increased mortality from complications of pulmonary hypertension in patients undergoing transcatheter aortic valve replacement.
    Pulm Circ. 2017;7:391-398.
    Abstract    

    Abstract available

  22. BOURJI KI, Kelemen BW, Mathai SC, Damico RL, et al
    Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction.
    Pulm Circ. 2017;7:409-420.
    Abstract    

    Abstract available

  23. SEGRERA SA, Lawler L, Opotowsky AR, Systrom D, et al
    Open label study of ambrisentan in patients with exercise pulmonary hypertension.
    Pulm Circ. 2017;7:531-538.
    Abstract    

    Abstract available

  24. SAYGIN D, Highland KB, Farha S, Park M, et al
    Metabolic and Functional Evaluation of the Heart and Lungs in Pulmonary Hypertension by Gated 2-[18F]-Fluoro-2-deoxy-D-glucose Positron Emission Tomography.
    Pulm Circ. 2017;7:428-438.
    Abstract    

    Abstract available

  25. ROTHMAN A, Restrepo H, Sarukhanov V, Evans WN, et al
    Assessment of microRNA and gene dysregulation in pulmonary hypertension by endoarterial biopsy.
    Pulm Circ. 2017;7:455-464.
    Abstract    

    Abstract available

  26. AWERBACH JD, Krasuski RA, Hill KD
    Characteristics of pediatric pulmonary hypertension trials registered on ClinicalTrials.gov.
    Pulm Circ. 2017;7:348-360.
    Abstract    

    Abstract available

  27. VENNER C, Odille F, Voilliot D, Chaouat A, et al
    Can MRI detect pulmonary hypertension in a population pre-selected by echocardiography?
    Acta Radiol. 2017 Jan 1:284185117712541. doi: 10.1177/0284185117712541.
    Abstract    

    Abstract available

  28. GUVENC O, Saygi M, Demir IH, Odemis E, et al
    [Closure of wide patent ductus arteriosus using a fenestrated muscular VSD occluder device in a pediatric patient with Down syndrome and pulmonary hypertension].
    Turk Kardiyol Dern Ars. 2017;45:373-376.
    Abstract    

    Abstract available

  29. WU YW, Hsu PY, Lin YH, Cheng MF, et al
    Diagnostic and Prognostic Implications of Exercise Treadmill and Rest First-Pass Radionuclide Angiography in Patients With Pulmonary Hypertension.
    Clin Nucl Med. 2017 Jun 5. doi: 10.1097/RLU.0000000000001720.
    Abstract    

    Abstract available

  30. LU Y, Guo H, Sun Y, Pan X, et al
    Valsartan attenuates pulmonary hypertension via suppression of mitogen activated protein kinase signaling and matrix metalloproteinase expression in rodents.
    Mol Med Rep. 2017 Jun 6. doi: 10.3892/mmr.2017.6706.
    Abstract    

    Abstract available

  31. KHAN KK, Khan FH
    Pulmonary hypertensive crisis and its efficient management. A Case report and literature review.
    J Pak Med Assoc. 2017;67:936-938.
    Abstract    

    Abstract available

  32. BROUSSEAU S, Wang Z, Gupta SK, Meenach SA, et al
    Development of Aerosol Phospholipid Microparticles for the Treatment of Pulmonary Hypertension.
    AAPS PharmSciTech. 2017 Jun 5. doi: 10.1208/s12249-017-0821.
    Abstract    

    Abstract available

  33. SZPOTANSKA-SIKORSKA M, Mazanowska N, Jankowski K, Lichodziejewska B, et al
    Favourable pregnancy outcome in a woman with secondary pulmonary hypertension complicating mitral stenosis.
    Ginekol Pol. 2017;88:276-277.
    Abstract    

    Abstract available

  34. POSER H, Berlanda M, Monacolli M, Contiero B, et al
    Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension.
    J Vet Cardiol. 2017 Jun 1. pii: S1760-2734(17)30081.
    Abstract    

    Abstract available

  35. BRUDERER S, Hurst N, Remenova T, Dingemanse J, et al
    Clinical pharmacology, efficacy, and safety of selexipag for the treatment of pulmonary arterial hypertension.
    Expert Opin Drug Saf. 2017;16:743-751.
    Abstract    

    Abstract available

  36. KOBAYASHI K, Murakami A, Komatsu S, Nishiyama K, et al
    [A Case of Stage IV Breast Cancer with Long-Term Survival by Chemotherapy Developing Pulmonary Tumor Thrombotic Microangiopathy during the Treatment Course].
    Gan To Kagaku Ryoho. 2017;44:243-246.
    Abstract    

    Abstract available

  37. LUKS AM, Swenson ER, Bartsch P
    Acute high-altitude sickness.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  38. SITBON O, Vonk Noordegraaf A
    Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  39. PANAGIOTOU M, Church AC, Johnson MK, Peacock AJ, et al
    Pulmonary vascular and cardiac impairment in interstitial lung disease.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  40. GUIGNABERT C, Bailly S, Humbert M
    Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.
    Expert Opin Ther Targets. 2017;21:181-190.
    Abstract    

    Abstract available

  41. BASCUNAN A, Thieman Mankin KM, Saunders AB, Bright JM, et al
    Patent ductus arteriosus in cats (Felis catus): 50 cases (2000-2015).
    J Vet Cardiol. 2017;19:35-43.
    Abstract    

    Abstract available

  42. NAUMBURG E, Soderstrom L, Huber D, Axelsson I, et al
    Risk factors for pulmonary arterial hypertension in children and young adults.
    Pediatr Pulmonol. 2017;52:636-641.
    Abstract    

    Abstract available

  43. CHON MK, Cho KI, Cha KS, Seo JS, et al
    Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome.
    J Cardiol. 2017;69:741-746.
    Abstract    

    Abstract available

  44. LI M, Zhang N, Zhou Y, Li J, et al
    A 50-year-old woman with haemoptysis, cough and tachypnea: cholesterol pneumonia accompanying with pulmonary artery hypertension.
    Clin Respir J. 2017;11:254-257.
    Abstract    

    Abstract available


  45. "Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension." Irene Lang, Bernhard C. Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer and Philippe Brenot. Eur Respir Rev 2017; 26: 160
    Eur Respir Rev. 2017;26.
    Abstract    



  46. SCHWAIGER JP, Knight DS, Kaier T, Gallimore A, et al
    Two-dimensional knowledge-based volumetric reconstruction of the right ventricle documents short-term improvement in pulmonary hypertension.
    Echocardiography. 2017 Jun 13. doi: 10.1111/echo.13541.
    Abstract    

    Abstract available

  47. SELVARAJ S, Shah SJ, Ommerborn MJ, Clark CR, et al
    Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study.
    Circ Heart Fail. 2017;10.
    Abstract    

    Abstract available

  48. MARTINEZ DE COMPANON Z, Poblet-Puig M, Valles G, Del Toro M, et al
    Cobalamin disorder CblC presenting with hemolytic uremic syndrome and pulmonary hypertension.
    Nefrologia. 2017 Jun 10. pii: S0211-6995(17)30092.
    Abstract    



  49. HALANK M, Hoeper MM, Ghofrani HA, Meyer FJ, et al
    Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
    Respir Med. 2017;128:50-56.
    Abstract    

    Abstract available

  50. KALUARACHCHI DC, Smith CJ, Klein JM, Murray JC, et al
    Polymorphisms in urea cycle enzyme genes are associated with persistent pulmonary hypertension of the newborn.
    Pediatr Res. 2017 Jun 13. doi: 10.1038/pr.2017.
    Abstract    

    Abstract available

  51. MALONEY JP
    Putting skin in the game: dermis-derived stem cells provide insight into familial pulmonary hypertension.
    Stem Cell Investig. 2017;4:35.
    Abstract    



  52. LI J, Ma JR, Sun ZX, Jiang JJ, et al
    [A clinical analysis of 15 children with systemic lupus erythematosus accompanied by pulmonary hypertension].
    Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:658-662.
    Abstract    

    Abstract available

  53. JUJO TS, Tanabe N, Sakao S, Sugiura T, et al
    EXPRESS: The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study.
    Pulm Circ. 2017 Jan 1:2045893217717258. doi: 10.1177/2045893217717258.
    Abstract    



  54. BAUMGART B, Guha M, Hennan J, Li J, et al
    In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension.
    Cancer Chemother Pharmacol. 2017;79:711-723.
    Abstract    

    Abstract available

  55. TAN TS, Ahmad S
    Acute dyspnoea in a paraplegic man.
    Br J Hosp Med (Lond). 2017;78:173.
    Abstract    



  56. CAO XF, Ma L, Ma S, Xu J, et al
    HMOX1 Promoter Microsatellite Polymorphism Is Not Associated With High Altitude Pulmonary Edema in Han Chinese.
    Wilderness Environ Med. 2017;28:17-22.
    Abstract    

    Abstract available

  57. TAKATSUKI S, Nakayama T, Ikehara S, Matsuura H, et al
    Pulmonary Arterial Capacitance Index Is a Strong Predictor for Adverse Outcome in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension.
    J Pediatr. 2017;180:75-79.
    Abstract    

    Abstract available

  58. KIM SY, Shin SH, Kim HS, Jung YH, et al
    Pulmonary Arterial Hypertension after Ibuprofen Treatment for Patent Ductus Arteriosus in Very Low Birth Weight Infants.
    J Pediatr. 2016 Sep 28. pii: S0022-3476(16)30886.
    Abstract    

    Abstract available

  59. SCHUBERT S, Peters B, Berger F
    Interventional re-opening of a PDA for reverse potts shunt circulation after ADO i implantation in a child.
    Catheter Cardiovasc Interv. 2017;89:E133-E136.
    Abstract    

    Abstract available

  60. GADRE A, Ghattas C, Han X, Wang X, et al
    Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study.
    Lung. 2017 Jun 23. doi: 10.1007/s00408-017-0034.
    Abstract    

    Abstract available

  61. KRISHNAN U, Feinstein JA, Adatia I, Austin ED, et al
    Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia.
    J Pediatr. 2017 Jun 20. pii: S0022-3476(17)30650.
    Abstract    



  62. JOSE A, Rafei H, Ahari J
    EXPRESS: Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension.
    Pulm Circ. 2017 Jan 1:2045893217716659. doi: 10.1177/2045893217716659.
    Abstract    



  63. TIMLIN MR, Black AB, Delaney HM, Matos RI, et al
    Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.
    Pediatr Cardiol. 2017 Jun 22. doi: 10.1007/s00246-017-1652.
    Abstract    

    Abstract available

  64. HARTING MT
    Congenital diaphragmatic hernia-associated pulmonary hypertension.
    Semin Pediatr Surg. 2017;26:147-153.
    Abstract    

    Abstract available

  65. D'ALESSANDRO A, El Kasmi K, Plecita-Hlavata L, Jezek P, et al
    Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.
    Antioxid Redox Signal. 2017 Jun 22. doi: 10.1089/ars.2017.7217.
    Abstract    

    Abstract available

  66. MOCERI P, Duchateau N, Baudouy D, Schouver ED, et al
    Three-dimensional right-ventricular regional deformation and survival in pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2017 Jun 15. doi: 10.1093.
    Abstract    

    Abstract available

  67. FAYED MA, Abdel-Hady HE, Hafez MM, Salama OS, et al
    Study of platelet activation, hypercoagulable state, and the association with pulmonary hypertension in children with beta-thalassemia.
    Hematol Oncol Stem Cell Ther. 2017 Jun 15. pii: S1658-3876(17)30083.
    Abstract    

    Abstract available

  68. ADLER AC, Nicole Chao YJ
    Adenotonsillectomy for the Management of Pulmonary Hypertension in a Patient With Complex Congenital Heart Disease: A Case Report.
    A A Case Rep. 2017 Jun 19. doi: 10.1213/XAA.0000000000000593.
    Abstract    

    Abstract available

  69. LIN Z, Jiang Z, Huang X, Cai X, et al
    Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Clin Exp Hypertens. 2017 Jun 19:1-7. doi: 10.1080/10641963.2016.1254225.
    Abstract    

    Abstract available

  70. SAMSON N, Paulin R
    Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension.
    Pulm Circ. 2017 Jun 19:2045893217714463. doi: 10.1177/2045893217714463.
    Abstract    

    Abstract available

  71. DU Y, Fu J, Yao L, Qiao L, et al
    Altered expression of PPARgamma and TRPC in neonatal rats with persistent pulmonary hypertension.
    Mol Med Rep. 2017 Jun 9. doi: 10.3892/mmr.2017.6744.
    Abstract    

    Abstract available

  72. GEVA A, Gronsbell JL, Cai T, Cai T, et al
    A Computable Phenotype Improves Cohort Ascertainment in a Pediatric Pulmonary Hypertension Registry.
    J Pediatr. 2017 Jun 15. pii: S0022-3476(17)30658.
    Abstract    

    Abstract available

  73. BIGNA JJ, Noubiap JJ, Nansseu JR, Aminde LN, et al
    Prevalence, incidence and aetiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis protocol.
    BMJ Open. 2017;7:e014768.
    Abstract    

    Abstract available

  74. SHARMA S, Lang IM
    Current understanding of the pathophysiology of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2017 Jun 12. pii: S0049-3848(17)30375.
    Abstract    

    Abstract available

  75. LAUNAY D, Sobanski V
    [Pulmonary hypertension screening in systemic sclerosis: The best strategy remains to be defined].
    Rev Med Interne. 2017 Jun 13. pii: S0248-8663(17)30520.
    Abstract    



  76. AMSALLEM M, Sweatt AJ, Aymami MC, Kuznetsova T, et al
    Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models.
    Circ Cardiovasc Imaging. 2017;10.
    Abstract    

    Abstract available

  77. GATFIELD J, Menyhart K, Wanner D, Gnerre C, et al
    Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low beta-Arrestin Recruitment and Desensitization Potential.
    J Pharmacol Exp Ther. 2017;362:186-199.
    Abstract    

    Abstract available

  78. KALUZNA-OLEKSY M, Araszkiewicz A, Migaj J, Lesiak M, et al
    "From right to left": The role of right heart catheterization in the diagnosis and management of left heart diseases.
    Adv Clin Exp Med. 2017;26:135-141.
    Abstract    

    Abstract available

  79. GENCHEVA DG, Menchev DN, Penchev DK, Tokmakova MP, et al
    An Incidental Finding of Heart Echinococcosis in a Patient with Infective Endocarditis: a Case Report.
    Folia Med (Plovdiv). 2017;59:110-113.
    Abstract    

    Abstract available

  80. SMITH MA
    Cardiovascular Disease Update: Foreword.
    FP Essent. 2017;454:2.
    Abstract    



  81. CHEN R, Yan J, Liu P, Wang Z, et al
    The role of nuclear factor of activated T cells in pulmonary arterial hypertension.
    Cell Cycle. 2017;16:508-514.
    Abstract    

    Abstract available

  82. NORBY U, Forsberg L, Wide K, Sjors G, et al
    Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy.
    Pediatrics. 2016;138.
    Abstract    

    Abstract available

  83. TSANG-A-SJOE MW, Bultink IE, Heslinga M, Voskuyl AE, et al
    Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
    Rheumatology (Oxford). 2017;56:121-128.
    Abstract    

    Abstract available

  84. CIANG NC, Pereira N, Isenberg DA
    Mixed connective tissue disease-enigma variations?
    Rheumatology (Oxford). 2017;56:326-333.
    Abstract    

    Abstract available

  85. CARO-DOMINGUEZ P, Compton G, Humpl T, Manson DE, et al
    Pulmonary arterial hypertension in children: diagnosis using ratio of main pulmonary artery to ascending aorta diameter as determined by multi-detector computed tomography.
    Pediatr Radiol. 2016.
    Abstract    

    Abstract available

  86. KOKKINIDIS DG, Oikonomou EK, Papanastasiou CA, Theochari CA, et al
    Methodological Remarks in the Meta-Analysis on the Impact of Baseline Pulmonary Hypertension on Post-Transcatheter Aortic Valve Implantation Outcomes.
    Am J Cardiol. 2017 May 8. pii: S0002-9149(17)30758.
    Abstract    



  87. HASHIMOTO R, Joshi SR, Jiang H, Capdevila JH, et al
    Cyp2c44 gene disruption is associated with increased hematopoietic stem cells: Implication in chronic hypoxia-induced pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2017 May 26:ajpheart.00785.2016.
    Abstract    

    Abstract available

  88. FULOP GA, Yabluchanskiy A
    Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2017 Jun 16:ajpheart.00320.2017.
    Abstract    

    Abstract available

  89. SONG S, Ayon RJ, Yamamura A, Yamamura H, et al
    Capsaicin-induced Ca2+ signaling is enhanced via upregulated TRPV1 channels in pulmonary artery smooth muscle cells from patients with idiopathic PAH.
    Am J Physiol Lung Cell Mol Physiol. 2017;312:L309-L325.
    Abstract    

    Abstract available

  90. MANKOUSKI A, Kantores C, Wong MJ, Ivanovska J, et al
    Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD.
    Am J Physiol Lung Cell Mol Physiol. 2017;312:L208-L216.
    Abstract    

    Abstract available

  91. BARNES JW, Dweik RA
    Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass.
    Am J Respir Crit Care Med. 2017;195:1558-1560.
    Abstract    



  92. ELMI-SARABI M, Deschamps A, Delisle S, Ased H, et al
    Aerosolized Vasodilators for the Treatment of Pulmonary Hypertension in Cardiac Surgical Patients: A Systematic Review and Meta-analysis.
    Anesth Analg. 2017 Jun 7. doi: 10.1213/ANE.0000000000002138.
    Abstract    

    Abstract available

  93. HUMBERT M, Coghlan JG, Ghofrani HA, Grimminger F, et al
    Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.
    Ann Rheum Dis. 2017;76:422-426.
    Abstract    

    Abstract available

  94. MROCZEK T, Demkow M, Moszura T, Morka A, et al
    Perventricular Implantation of Melody Valve in Child With Pulmonary Hypertension After a Potts Shunt.
    Ann Thorac Surg. 2017;104:e67-e69.
    Abstract    

    Abstract available

  95. ZHOU Q, Wang D, Liu Y, Yang X, et al
    Solnatide Demonstrates Profound Therapeutic Activity in a Rat Model of Pulmonary Edema Induced by Acute Hypobaric Hypoxia and Exercise.
    Chest. 2017;151:658-667.
    Abstract    

    Abstract available

  96. WAXMAN AB, McElderry HT, Gomberg-Maitland M, Burke MC, et al
    Totally Implantable Intravenous Treprostinil Therapy in Pulmonary Hypertension: Assessment of the Implantation Procedure.
    Chest. 2017 Jun 2. pii: S0012-3692(17)31021-8. doi: 10.1016/j.chest.2017.
    Abstract    

    Abstract available

  97. KAY JM
    Crotalaria (Monocrotaline) Pulmonary Hypertension: The Fiftieth Anniversary.
    Chest. 2017 Jun 19. pii: S0012-3692(17)31082-6. doi: 10.1016/j.chest.2017.
    Abstract    



  98. HARARI S, Elia D, Humbert M
    Pulmonary hypertension in parenchymal lung diseases: any future for new therapies?
    Chest. 2017 Jun 16. pii: S0012-3692(17)31077-2. doi: 10.1016/j.chest.2017.
    Abstract    

    Abstract available

  99. ONG MS, Mullen MP, Austin ED, Szolovits P, et al
    Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension.
    Circ Res. 2017 Jun 13. pii: CIRCRESAHA.117.310804.
    Abstract    

    Abstract available

  100. KORSHOLM K, Andersen A, Mellemkjaer S, Nielsen DV, et al
    Results from more than 20 years of surgical pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Denmark.
    Eur J Cardiothorac Surg. 2017 Jun 7. doi: 10.1093.
    Abstract    

    Abstract available

  101. OLSSON KM, Wiedenroth CB, Kamp JC, Breithecker A, et al
    Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.
    Eur Respir J. 2017;49.
    Abstract    

    Abstract available

  102. PILANIA RK, Dhawan SR, Mathew JL, Singh S, et al
    ANCA-associated Vasculitis Presenting as Severe Pulmonary Hypertension and Right Heart Failure.
    Indian J Pediatr. 2017 Jun 2. doi: 10.1007/s12098-017-2379.
    Abstract    

    Abstract available

  103. KANWAR MK
    Survival in pulmonary hypertension: Experiences from a referral center.
    J Heart Lung Transplant. 2017 May 15. pii: S1053-2498(17)31795.
    Abstract    



  104. DEVRIES LB, Heyne RJ, Ramaciotti C, Brown LS, et al
    Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension.
    J Perinatol. 2017 Jun 15. doi: 10.1038/jp.2017.
    Abstract    

    Abstract available

  105. PARK DW, Sebastiani A, Yap CH, Simon MA, et al
    Quantification of Coupled Stiffness and Fiber Orientation Remodeling in Hypertensive Rat Right-Ventricular Myocardium Using 3D Ultrasound Speckle Tracking with Biaxial Testing.
    PLoS One. 2016;11:e0165320.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;